Onbrez Breezhaler - Indacaterol
Novartis Consumer Health
Description
Long-acting selective beta2 agonist.
• Over 18 years, by inhalation of powder: 150 mcg, once daily, increased to a maximum of 300 mcg once daily.
Indications
For the maintenance treatment of COPD.
Contraindications
Advised to avoid in the case of hepatic impairment, pregnancy or breast feeding.
Preparations Available
Inhalation powder
Sizes Available
Onbrez Breezhaler 150 mcg capsules with device, 30 capsulesÂ
Onbrez Breezhaler 300 mcg capsules with device, 30 capsules
More on: Bronchodilators , Long-acting selective beta2: agonists